Buckhalter Matthew 4

What Happened
Matthew Buckhalter, Chief Financial Officer of Aveanna Healthcare (AVAH), reported three sales between Feb 17–19, 2026. The transactions total 36,030 shares disposed for aggregate proceeds of approximately $266,097: 9,351 shares at $7.65 ($71,489) on Feb 17; 13,167 shares at $7.38 ($97,211) on Feb 18; and 13,512 shares at $7.21 ($97,397) on Feb 19. These are sales (not purchases) and per the filing appear to include automatic sales to satisfy tax withholding on vested equity.

Key Details

• Transaction dates and amounts:
  • 2026-02-17: 9,351 shares @ $7.65 = $71,489
  • 2026-02-18: 13,167 shares @ $7.38 = $97,211
  • 2026-02-19: 13,512 shares @ $7.21 = $97,397
• Total: 36,030 shares sold for ~$266,097.
• Shares owned after the transactions: not specified in the provided filing.
• Footnotes of note:
  • F1: Some shares were automatically sold to satisfy the reporting person's tax obligation upon vesting of equity awards.
  • F2–F4: Prices shown may be weighted averages from aggregate sales handled by the company’s stock plan administrator; price ranges for those aggregated lines are provided in the filing and the reporting person will supply per-price details to the SEC or company upon request.
• Filing timeliness: Form 4 was filed on Feb 19, 2026 covering transactions from Feb 17–19; no late filing indication in the provided information.

Context
These sales appear routine and include tax-withholding dispositions tied to vested awards rather than open-market purchases that might signal new insider conviction. For retail investors, purchases generally carry more informational weight than routine sales; here the filing documents tax-related and plan-administered sales rather than a directional trade by the insider.